Clinical Trial of Transcatheter Arterial Chemoembolization With KMG Microsphere Treating Advance-stage Hepatocellular Carinomas
This is a prospective, multicentre, random, controlled clinical trial of Transcatheter
Arterial Chemoembolization (TACE)with KMG Microsphere Treating Advance-stage Hepatocellular
Carinomas.
Interventional
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
Time to progression
Time to progression
3 years
No
Zhi Guo, MD
Study Chair
Tianjin Medical University Cancer Hospital
China: Ethics Committee
TMU-CIH-IR-002
NCT01393093
March 2011
March 2014
Name | Location |
---|